Abstract
This communication describes the synthesis of a new class of N-hydroxyguanidine (NHG) pro-drugs which release nitric oxide (NO), triggered by the action of gamma-glutamyl transpeptidase (gamma-GT), and have potential for the treatment of acute renal injury/failure (ARI/ARF).
Original language | English |
---|---|
Pages (from-to) | 1389-1391 |
Number of pages | 3 |
Journal | Chemical Communications |
Volume | 49 |
Issue number | 14 |
Early online date | 21 Dec 2012 |
DOIs | |
Publication status | Published - 2013 |
Keywords
- Nitric-oxide synthases
- Cardiac-surgery
- rat-kidney
- Injury
- Hydroxyguanidines
- Failure
- Oxidation
- Strategy
- Prodrugs
- DOPA